Objective: To analyze, in morbid obese patients, the expression of several human genes regulating cortisol metabolism, such as glucocorticoid receptor (GR), 11b-hydroxysteroid dehydrogenase type 1 (11bHSD1), 11b-hydroxysteroid dehydrogenase type 2 (11bHSD2), stearoyl-acute regulatory protein (StAR), 5a-reductase type I (5a-R) and peroxisome proliferator-activated receptor-g (PPARg) in two different adipose depots. A second objective was to characterize the circadian rhythmicity of these genes in both adipose tissue (AT) regions. Design: Visceral and subcutaneous abdominal AT biopsies were obtained from obese patients (body mass index X40 kg m À2 ). To carry out rhythmic expression analysis, AT explants were cultured for 24 h and gene expression at times (T ) 0, 6, 12 and 18 h, was performed with quantitative real-time PCR. Result: GR, 11bHSD1 and PPARg genes were highly expressed in both subcutaneous and visceral depots. StAR and 5a-R genes were detected at lower levels. The expression of 11bHSD2 was quantified in both AT depots with a higher expression in the visceral depot (P ¼ 0.032). Both sexes had similar gene expression levels, except for 5a-R (P ¼ 0.002). The genes studied showed circadian rhythmicity being more robust in visceral than in subcutaneous AT. Genes ranged in anti-phase between both depots (P ¼ 0.002). This rhythmicity was maintained in an AT culture. Conclusion: We have shown for the first time circadian rhythmicity in glucocorticoid-related gene expression in human AT ex vivo. These results may have potential therapeutic implications with respect to the pathogenesis and treatment of diseases, such as obesity, type 2 diabetes and cardiovascular diseases.